Inicia sesión Registrate Mi Biblioteca idioma

Idioma

biblioteca idioma abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará la selección de artículos sobre Trastornos del Movimiento clasificados según los 11 tipos establecidos por International Parkinson & Movement Disorder Society.

Corea y enfermedad de Huntington

347 ARTíCULOS , VIENDO DEL 31 AL 45

PUBMED

Mutational analysis implicates the amyloid fibril as the toxic entity in Huntington's disease.

Drombosky KW, Rode S, Kodali R, Jacob TC, Palladino MJ, Wetzel R.

Neurobiol Dis. 2018 Aug 29. pii: S0969-9961(18)30508-4. doi: 10.1016/j.nbd.2018.08.019. [Epub ahead of print]

0

0

0

PUBMED

Altered Intracortical T(1)-Weighted/T(2)-Weighted Ratio Signal in Huntington's Disease.

Rowley CD, Tabrizi SJ, Scahill RI, Leavitt BR, Roos RAC, Durr A, Bock NA.

Front Neurosci. 2018 Nov 5;12:805. doi: 10.3389/fnins.2018.00805. eCollection 2018.

0

0

0

PUBMED

Deubiquitinase Usp12 functions noncatalytically to induce autophagy and confer neuroprotection in models of Huntington's disease.

Aron R, Pellegrini P, Green EW, Maddison DC, Opoku-Nsiah K, Wong JS, Daub AC, Giorgini F, Finkbeiner S.

Nat Commun. 2018 Sep 28;9(1):3191. doi: 10.1038/s41467-018-05653-z.

0

0

0

PUBMED

A whole brain longitudinal study in the YAC128 mouse model of Huntington's disease shows distinct trajectories of neurochemical, structural connectivity and volumetric changes.

Petrella LI, Castelhano JM, Ribeiro M, Sereno JV, Gonçalves SI, Laço MN, Hayden MR, Rego AC, Castelo-Branco M.

Hum Mol Genet. 2018 Jun 15;27(12):2125-2137. doi: 10.1093/hmg/ddy119.

0

0

0

PUBMED

Effects of Stimulus-Related Variables on Mental States Recognition in Huntington'S Disease.

Belardinelli MO, Huenefeldt T, Maffi S, Squitieri F, Migliore S.

Int J Neurosci. 2018 Nov 27:1-21. doi: 10.1080/00207454.2018.1552691. [Epub ahead of print]

0

0

0

PUBMED

Structural and metabolic brain correlates of apathy in Huntington's disease.

Martínez-Horta S, Perez-Perez J, Sampedro F, Pagonabarraga J, Horta-Barba A, Carceller-Sindreu M, Gomez-Anson B, Lozano-Martinez GA, Lopez-Mora DA, Camacho V, Fernández-León A, Carrió I, Kulisevsky J.

Mov Disord. 2018 Jul;33(7):1151-1159. doi: 10.1002/mds.27395. Epub 2018 Apr 20.

0

0

0

PUBMED

Identification of differentially expressed genes and regulatory relationships in Huntington's disease by bioinformatics analysis.

Dong X, Cong S.

Mol Med Rep. 2018 Mar;17(3):4317-4326. doi: 10.3892/mmr.2018.8410. Epub 2018 Jan 9.

0

0

0

PUBMED

hPSC-Derived Striatal Cells Generated Using a Scalable 3D Hydrogel Promote Recovery in a Huntington Disease Mouse Model.

Adil MM, Gaj T, Rao AT, Kulkarni RU, Fuentes CM, Ramadoss GN, Ekman FK, Miller EW, Schaffer DV.

Stem Cell Reports. 2018 Apr 3. pii: S2213-6711(18)30134-6. doi: 10.1016/j.stemcr.2018.03.007. [Epub ahead of print]

0

0

0

PUBMED

Drp1/Fis1-mediated mitochondrial fragmentation leads to lysosomal dysfunction in cardiac models of Huntington's disease.

Joshi AU, Ebert AE, Haileselassie B, Mochly-Rosen D.

J Mol Cell Cardiol. 2018 Dec 11;127:125-133. doi: 10.1016/j.yjmcc.2018.12.004. [Epub ahead of print]

0

0

0

PUBMED

Early Detection of Apathetic Phenotypes in Huntington's Disease Knock-in Mice Using Open Source Tools.

Minnig S, Bragg RM, Tiwana HS, Solem WT, Hovander WS, Vik ES, Hamilton M, Legg SRW, Shuttleworth DD, Coffey SR, Cantle JP, Carroll JB.

Sci Rep. 2018 Feb 2;8(1):2304. doi: 10.1038/s41598-018-20607-7.

0

0

0

PUBMED

Safety and efficacy of pridopidine in patients with Huntington's disease (PRIDE-HD): a phase 2, randomised, placebo-controlled, multicentre, dose-ranging study.

Reilmann R, McGarry A, Grachev ID, Savola JM, Borowsky B, Eyal E, Gross N, Langbehn D, Schubert R, Wickenberg AT, Papapetropoulos S, Hayden M, Squitieri F, Kieburtz K, Landwehrmeyer GB; European Hunti

Lancet Neurol. 2018 Dec 14. pii: S1474-4422(18)30391-0. doi: 10.1016/S1474-4422(18)30391-0. [Epub ahead of print]

0

0

0

PUBMED

Bilateral Striatal Necrosis after Sydenham's Chorea in a 7-Year-Old Boy: A 2-Year Follow-Up.

Canavese C, Davico C, Casabianca M, Olivieri C, Mancini S, Migliore G, Versace A, Tocchet A, Vitiello B.

Neuropediatrics. 2018 Feb 22. doi: 10.1055/s-0037-1618590. [Epub ahead of print]

0

0

0

PUBMED

Salivary levels of total huntingtin are elevated in Huntington's disease patients.

Corey-Bloom J, Haque AS, Park S, Nathan AS, Baker RW, Thomas EA.

Sci Rep. 2018 May 9;8(1):7371. doi: 10.1038/s41598-018-25095-3.

0

0

0

PUBMED

AAV5-miHTT Gene Therapy Demonstrates Broad Distribution and Strong Human Mutant Huntingtin Lowering in a Huntington's Disease Minipig Model.

Evers MM, Miniarikova J, Juhas S, Vallès A, Bohuslavova B, Juhasova J, Skalnikova HK, Vodicka P, Valekova I, Brouwers C, Blits B, Lubelski J, Kovarova H, Ellederova Z, van Deventer SJ, Petry H, Motlik

Mol Ther. 2018 Sep 5;26(9):2163-2177. doi: 10.1016/j.ymthe.2018.06.021. Epub 2018 Jun 25.

0

0

0

PUBMED

Huntington Mice Demonstrate Diminished Pain Response in Inflammatory Pain Model.

Lin YC, Hsiao HT, Wu SN, Liu YC.

Anesth Analg. 2018 Feb;126(2):661-669. doi: 10.1213/ANE.0000000000002419.

0

0

0

Comentarios

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo HONcode Logo WIS

En colaboración con:

Zambon Neuroacademy